πŸ‡ΊπŸ‡Έ FDA
Patent

US 8765797

TG2 inhibitors and uses thereof

granted A61KA61K31/381A61K31/41

Quick answer

US patent 8765797 (TG2 inhibitors and uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/381, A61K31/41, A61P, A61P35/00